Market Overview - The chemical pharmaceutical sector experienced a slight decline of 0.05% on September 8, with Chenxin Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3826.84, up 0.38%, while the Shenzhen Component Index closed at 12666.84, up 0.61% [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Jincheng Pharmaceutical (300233) with a closing price of 20.83, up 7.04% and a trading volume of 452,000 shares, totaling 934 million yuan [1] - Haichen Pharmaceutical (300584) closed at 77.88, up 6.39% with a trading volume of 196,500 shares, totaling 1.481 billion yuan [1] - Fosun Pharmaceutical (600196) closed at 32.08, up 6.26% with a trading volume of 912,400 shares, totaling 2.928 billion yuan [1] - Conversely, the following companies faced significant declines: - Chenxin Pharmaceutical (603367) closed at 23.04, down 8.61% with a trading volume of 318,300 shares, totaling 758 million yuan [2] - Maiwei Biotechnology (688062) closed at 53.60, down 7.94% with a trading volume of 198,400 shares, totaling 1.082 billion yuan [2] - Yifang Biotechnology (688382) closed at 38.40, down 7.85% with a trading volume of 172,300 shares, totaling 667 million yuan [2] Capital Flow - The chemical pharmaceutical sector saw a net outflow of 1.254 billion yuan from institutional investors, while retail investors contributed a net inflow of 922 million yuan [2] - The following stocks had notable capital flows: - Renfu Pharmaceutical (600079) had a net inflow of 97.1863 million yuan from institutional investors, but a net outflow of 85.0615 million yuan from retail investors [3] - Xintai (002294) saw a net inflow of 64.6380 million yuan from institutional investors, with retail investors experiencing a net outflow of 32.4393 million yuan [3] - Haichen Pharmaceutical (300584) had a net inflow of 33.1330 million yuan from institutional investors, but a net outflow of 92.6533 million yuan from retail investors [3]
化学制药板块9月8日跌0.05%,辰欣药业领跌,主力资金净流出12.54亿元